WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018138541) GLYCOPEPTIDE DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION AND/OR ATTENUATION OF FIBROSIS DISEASES
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/138541 International Application No.: PCT/IB2017/000207
Publication Date: 02.08.2018 International Filing Date: 30.01.2017
IPC:
A61K 31/70 (2006.01) ,C07K 5/09 (2006.01) ,C07K 5/068 (2006.01) ,A61P 17/02 (2006.01) ,A61P 43/00 (2006.01)
Applicants: TFCHEM[FR/FR]; Pharma Parc II Voie De L´innovation Bâtiment C 27100 Val de Reuil, FR
Inventors: DELIENCOURT-GODEFROY, Géraldine; FR
LEGOEDEC, Jocelyne; FR
Agent: REGIMBEAU; 20, rue de Chazelles 75847 Paris Cedex 17, FR
Priority Data:
Title (EN) GLYCOPEPTIDE DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION AND/OR ATTENUATION OF FIBROSIS DISEASES
(FR) DÉRIVÉS DE GLYCOPEPTIDES DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT ET/OU LA PRÉVENTION ET/OU L'ATTÉNUATION DE MALADIES DE FIBROSE
Abstract: front page image
(EN) The present invention relates to a compound of the following formula (I), as well as to a pharmaceutical composition comprising at least one compound of following formula (I) and at least one pharmaceutically acceptable excipient, for use in the treatment and/or prevention and/or attenuation of fibrosis diseases, in particular excessive scars such as keloids or hypertrophic scars.
(FR) La présente invention concerne un composé de la formule suivante (I), ainsi qu'une composition pharmaceutique comprenant au moins un composé de la formule suivante (I) et au moins un excipient pharmaceutiquement acceptable, destinée à être utilisée le traitement et/ou la prévention et/ou l'atténuation de maladies de fibrose, en particulier des cicatrices excessives telles que des chéloïdes ou des cicatrices hypertrophiques.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)